Physician profile
Michael Mccaughan
NPI 1316206022
$3,952.74
in general payments reported to CMS, 2019-2025
9 companies · $2,299 in 2025
The $2,299 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.72 · 2021: $1,220 · 2022: $326 · 2023: $46.41 · 2024: $48.88 · 2025: $2,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,578 · Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,577.58 |
| Food and Beverage | $816.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,280.92 | 2024-2025 | Evoque, Sapien 3 Ultra Resilia |
| Intuitive Surgical, INC. | $1,427.98 | 2021-2022 | |
| Medtronic, INC. | $76.48 | 2021-2023 | Corevalve Evolut R |
| Merck Sharp & Dohme LLC | $60.28 | 2021-2025 | Bridion |
| Fisher & Paykel Healthcare INC | $33.45 | 2025 | Fisher & Paykel Healthcare |
| La Jolla Pharmaceutical Company | $29.84 | 2022 | |
| Atricure, INC. | $16.28 | 2021 | |
| Teleflex LLC | $14.79 | 2023 | Manta |
| B. Braun Medical INC. | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mccaughan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.